Showing results (21-30 of 21,659) with videos related to
Sort By:
Pageof 2,166
ACS Infectious Diseases|March 1, 2021
Boceprevir, Calpain Inhibitors II and XII, and GC-376 Have Broad-Spectrum Antiviral Activity against CoronavirusesYanmei Hu, Chunlong Ma, Tommy Szeto, et al.Biorxiv : the Preprint Server for Biology|November 3, 2020
Boceprevir, calpain inhibitors II and XII, and GC-376 have broad-spectrum antiviral activity against coronaviruses in cell cultureYanmei Hu, Chunlong Ma, Tommy Szeto, et al.International Journal of Molecular Sciences|September 9, 2017
Chemical Genomics Approach Leads to the Identification of Hesperadin, an Aurora B Kinase Inhibitor, as a Broad-Spectrum Influenza AntiviralYanmei Hu, Jiantao Zhang, Rami Musharrafieh, et al.Antiviral Research|August 6, 2017
Discovery of dapivirine, a nonnucleoside HIV-1 reverse transcriptase inhibitor, as a broad-spectrum antiviral against both influenza A and B virusesYanmei Hu, Jiantao Zhang, Rami Ghassan Musharrafieh, et al.European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|April 2, 2019
Identification of NMS-873, an allosteric and specific p97 inhibitor, as a broad antiviral against both influenza A and B virusesJiantao Zhang, Yanmei Hu, Raymond Hau, et al.Journal of Virology|January 25, 2019
Validating Enterovirus D68-2Apro as an Antiviral Drug Target and the Discovery of Telaprevir as a Potent D68-2Apro InhibitorRami Musharrafieh, Chunlong Ma, Jiantao Zhang, et al.Antiviral Research|January 15, 2017
An M2-V27A channel blocker demonstrates potent in vitro and in vivo antiviral activities against amantadine-sensitive and -resistant influenza A virusesYanmei Hu, Rami Musharrafieh, Chunlong Ma, et al.Biorxiv : the Preprint Server for Biology|September 30, 2020
Ebselen, disulfiram, carmofur, PX-12, tideglusib, and shikonin are non-specific promiscuous SARS-CoV-2 main protease inhibitorsChunlong Ma, Yanmei Hu, Julia Alma Townsend, et al.Journal of Medicinal Chemistry|January 18, 2018
In Vitro Pharmacokinetic Optimizations of AM2-S31N Channel Blockers Led to the Discovery of Slow-Binding Inhibitors with Potent Antiviral Activity against Drug-Resistant Influenza A VirusesYuanxiang Wang, Yanmei Hu, Shuting Xu, et al.ACS Medicinal Chemistry Letters|November 16, 2018
Structure-Property Relationship Studies of Influenza A Virus AM2-S31N Proton Channel BlockersYanmei Hu, Raymond Kin Hau, Yuanxiang Wang, et al.Pageof 2,166